Update

Search This Blog

Biogen’s Alzheimer’s drug is unlikely to win E.U. approval.

November 17, 2021

Get link
Facebook
X
Pinterest
Email
Other Apps

By Rebecca Robbins | NYTimes NYT > World > Europe | Disclosure

Get link
Facebook
X
Pinterest
Email
Other Apps

Comments

Countries Weigh How to Raise Trillions for Climate Crisis at COP29

Low-income countries need at least $1 trillion a year to manage climate change. Donald Trump’s victory just made that more difficult, but options exist. By Somini Sengupta and Lydia DePillis | NYTimes NYT > World > Europe | Disclosure

Airbnb ‘Gladiator’ Experience at the Colosseum Prompts Outcry in Rome

An initiative by officials at the monument in a partnership with Airbnb has prompted an outcry among those who feel it will demean a cultural treasure. By Elisabetta Povoledo | NYTimes NYT > World > Europe | Disclosure

Notre-Dame Cathedral Reopening Ceremony: How to Watch and Schedule

A speech by President Emmanuel Macron and a religious service will precede the broadcast of a taped concert by French and international musical artists. By Aurelien Breeden and Ségolène Le Stradic | NYTimes NYT > World > Europe | Disclosure

Writers Silenced by Stalin Get New Life Amid War in Ukraine

The Soviet regime killed a generation of literary artists in the 1930s. Their legacy is being reclaimed as Ukraine fights to preserve its cultural heritage. By Constant Méheut | NYTimes NYT > World > Europe | Disclosure

Cajole, Plead and Flatter: Ukraine Makes Its Case to Trump

Using diplomacy, flattery and the occasional shot in the dark, Ukraine is doing everything it can to win over President-elect Donald J. Trump to its side. By Constant Méheut, Kim Barker and Maria Varenikova | NYTimes NYT > World > Europe | Disclosure

Biogen’s Alzheimer’s drug is unlikely to win E.U. approval.

Comments

Post a Comment